Gaziantep University is a public university in Gaziantep, Turkey. Gaziantep University has 10 faculties, containing a total of 22 academic departments, with a strong emphasis on scientific and technological research. Gaziantep is the largest trade and industrial center in the west of Southeastern Turkey.

During the past decade, Gaziantep University Medical Faculty conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 4 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 2 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Gaziantep University Medical Faculty" #1 sponsor was "Hoffmann-La Roche" with 3 trials, followed by "Eli Lilly and Company" with 2 trials sponsored, "Pfizer" with 2 trials sponsored, "Abbott Nutrition" with 1 trials sponsored and "Agennix" with 1 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Gaziantep University Medical Faculty" #1 collaborator was "Klinar CRO" with 2 trials as a collaborator, "Abbott Nutrition" with 1 trials as a collaborator, "CenTrial GmbH" with 1 trials as a collaborator, "Hoffmann-La Roche" with 1 trials as a collaborator and "Pharmasolutions4U" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Gaziantep University Medical Faculty" are "Acute Ischemic Stroke" (1 trials), "Breast Cancer" (1 trials), "Breast Neoplasms" (1 trials), "COVID-19" (1 trials) and "Chronic Widespread Pain" (1 trials). Many other conditions were trialed in "Gaziantep University Medical Faculty" in a lesser frequency.

Most popular intervention types in "Gaziantep University Medical Faculty" are "Drug" (13 trials), "Biological" (1 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Paclitaxel" (2 trials), "Allopurinol" (1 trials), "Atezolizumab" (1 trials) and "Atezolizumab Matching Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Gaziantep University Medical Faculty" are 16 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Gaziantep University Medical Faculty". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Gaziantep University Medical Faculty, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Gaziantep University Medical Faculty, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".